BLRX

BioLineRX
BLRX

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $6.74M invested in BioLineRX in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$134K
2
+$123K
3
+$7.02K
4
UBS Group
UBS Group
Switzerland
+$3K
5
PVH
Psagot Value Holdings
Israel
+$1K

Top Sellers

1
-$263K
2
-$65K
3
-$31K
4
CCB
Cutter & Co Brokerage
Missouri
-$21K
5
MCC
Malaga Cove Capital
California
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.58M
2
$1.33M
3
$384K
4
$183K
5
$123K
6
$65K
7
$44K
8
$20K
9
$10K
10
$7K
11
$3K
12
$1K
13
$1K
14
$34
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2